Alkeon Capital Management
SRPT icon

Alkeon Capital Management’s Sarepta Therapeutics SRPT Stock Holding History

Alkeon Capital Management’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-853,845
Closed -$54.5M – 116
2025
Q1 		$54.5M Hold
853,845
– – 0.11% 70
2024
Q4 		$104M Buy
853,845
+220,000
+35% +$27M 0.21% 53
2024
Q3 		$79.2M Buy
633,845
+75,000
+13% +$10.4M 0.14% 64
2024
Q2 		$88.3M Buy
558,845
+100,000
+22% +$12.8M 0.14% 68
2024
Q1 		$59.4M Buy
458,845
+100,000
+28% +$12.2M 0.1% 76
2023
Q4 		$34.6M Sell
358,845
-100,000
-22% -$9.59M 0.08% 80
2023
Q3 		$55.6M Sell
458,845
-50,000
-10% -$5.65M 0.1% 76
2023
Q2 		$58.3M Sell
508,845
-203,989
-29% -$26.3M 0.1% 80
2023
Q1 		$98.2M Buy
712,834
+39,222
+6% +$5.09M 0.22% 69
2022
Q4 		$87.3M Sell
673,612
-557,784
-45% -$64.6M 0.34% 70
2022
Q3 		$136M Buy
1,231,396
+75,000
+6% +$7.56M 0.44% 53
2022
Q2 		$86.7M Sell
1,156,396
-19,400
-2% -$1.43M 0.23% 78
2022
Q1 		$91.9M Buy
1,175,796
+80,796
+7% +$6.19M 0.18% 97
2021
Q4 		$98.6M Buy
1,095,000
+1,006,000
+1,130% +$86M 0.18% 95
2021
Q3 		$8.23M Buy
+89,000
New +$6.86M 0.01% 161
2020
Q1 		– Sell
-20,000
Closed -$2.58M – 148
2019
Q4 		$2.58M Buy
+20,000
New +$2.02M 0.01% 122

Other funds holding SRPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Alkeon Capital Management's SRPT Position: Q2 2025 in Review

Alkeon Capital Management sold out of Sarepta Therapeutics (SRPT) in Q2 2025, closing a stake of 853,845 shares — an estimated $54.5M sold.

Alkeon Capital Management first reported a position in SRPT in Q4 2019 and held it in 16 quarters. The position peaked at $136M in Q3 2022. 362 funds tracked by Wall St. Rank hold SRPT as of Q2 2025.

  • Alkeon Capital Management reported no remaining Sarepta Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Alkeon Capital Management sold 853,845 Sarepta Therapeutics shares in Q2 2025, an estimated $54.5M.
  • Alkeon Capital Management first reported a position in Sarepta Therapeutics in Q4 2019 and held it in 16 quarters.
  • Alkeon Capital Management's Sarepta Therapeutics position peaked at $136M in Q3 2022.
  • 362 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2025.

Based on Alkeon Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.